PPT-The Trust-TSC Phase 3 Clinical Trial for Seizures in TSC

Mary Kay Koenig MD Associate Vice Chair for Clinical Research CoDirector for the Tuberous Sclerosis Center of Excellence Department of Pediatrics Division of Child amp Adolescent Neurology University of Texas McGovern Medical School. (aka---how to know where to look and who to call). GIST. Rare disease, 5000-7000 new cases of GIST every year . Compare 230,000 new invasive breast CA cases/year. GIST studies tend to be opened at fewer sites . David N. Assis, MD. Assistant Professor of Medicine. Yale University. I have no disclosures relevant to this presentation.. Clinical Trials in PSC. PSC is a rare disease . 32,000 patients in the US. PSC has no proven and approved treatment. Colorado School of Public Health. January 30. th. , 2013. Table of Contents. Orientation. Introduction. Components of a Phase I Trial. Phase I Trial Designs. Rule-Based Designs. Statistical Designs. References. (emphasis on fruits and vegetables and their components). Steven K. Clinton, M.D., Ph.D.. The Ohio State University. 2. Introduction. 3. What is a Clinical Trial:. Essential Characteristics. “a . prospective. Brenda Porter MD, PhD. Cannabis: A complex mixture of chemicals. Disclosures. Dr. Porter has received compensation for working on an advisory board for . Upsher. -Smith, a data safety monitoring board for a clinical trial run by Greenwich Biosciences, and has through marriage received stock and compensation from Johnson and Johnson. . . Angelman Society of Israel. November 29th, 2018. ד"ר ג'רמי לוין. יו"ר ומנכ"ל. Forward-Looking Statements. This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "plan," "anticipate" and similar expressions (as well as other words or expressions referencing future events or circumstances) are intended to identify forward-looking statements. Forward-looking statements contained in this presentation include statements about the progress, timing, clinical development and scope of clinical trials and the reporting of clinical data for the Company’s product candidates; the potential clinical benefit of the Company’s product candidates; and the timing and outcome of discussions with regulatory authorities. Each of these forward-looking statements involves risks and uncertainties. These statements are based on the Company’s current expectations and projections made by management and are not guarantees of future performance. Therefore, actual events, outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. Factors that may cause actual results to differ materially from these forward-looking statements are discussed in the Company’s filings with the U.S. Securities and Exchange Commission, including the "Risk Factors" sections contained therein. Except as otherwise required under federal securities laws, we do not have any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, changes in assumptions or otherwise.. Professor Julia . Brown. Leeds Institute of Clinical Trials Research, University of Leeds. Introduction. First clinical trial in 1747, James Lind. Clinical trials are gold standard for the evaluation of new treatments/interventions in health care . Marina Di Marco. Principal Neuromuscular Physiotherapist. The changing landscape of research in DMD. Emily Crossley and Alex Johnson (co-founders of Duchenne UK and parents of children with DMD) were disappointed that clinical trials were being turned down in the UK because of lack of capacity.. Collecting data. 2. Data . Statistics is a way of thinking—thinking about ways to . gather. and analyze data.. Trust data. 3. 3. Resource of Data. Experiment/ clinical trial. Survey. http://www.nhs.uk/Conditions/Clinical-trials/Pages/Healthresearch.aspx. Outline. Review of a phase I trial. What is a phase II trial?. Phase II trial process. Standard trial designs. Innovative trial designs. Phase II trial examples. Guess that trial. Phase II thalidomide study. Covered in this presentation. Basic information about clinical trials. Information about finding a clinical trial. Information about participating in or leaving a clinical trial . Vision. Mission. Make Ontario a preferred location for global clinical trials, while maintaining the highest ethical standards.. CUP . . Harpreet S. Wasan. Consultant / Reader in Medical oncology. Department of Cancer Medicine. Hammersmith Hospital,. . Imperial College London. h.wasan. @. imperial.ac.uk. Microarray . Identifies . Karen-Sue Carlson, MD, PhD. Associate Professor of Medicine. Division of Hematology and Oncology. Section Head and Medical Director of Acute Care. Medical College of Wisconsin. Milwaukee, WI. What are clinical trials?. A Feasibility Study. SciSIP. PI Conference, September 2012. Ernst R. Berndt. Iain M. Cockburn. MIT, Boston University, and . National Bureau of Economic Research. What?. Analysis of trends in costs of doing clinical trials.